Patent · US Active

Treatment of amyotrophic lateral sclerosis (ALS)

US11931375B2 · kind B2 · utility

1Cited by

222References

24Claims

0Family size

Assignee

VOYAGER THERAPEUTICS, INC. · US

Inventors

Dinah Wen-Yee Sah · Boston, US
Holger Patzke · Cambridge, US
Qingmin Chen · Wuxi, CN
Jenna Carroll Soper · Winchester, US

Key dates

Filing date	Mar 22, 2022
Grant date	Mar 19, 2024
Priority date	—
Expiry date	Mar 22, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2750/14143
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to AAVs encoding a SOD1 targeting polynucleotide which may be used to treat amyotrophic lateral sclerosis (ALS) and delivery methods for the treatment of spinal cord related disorders including ALS.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.